Research Article

NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation

Figure 2

NPT1220-312 blocks TLR2 signaling mediated by natural TLR2 pathogen agonists: (a) concentration-response curves for P. gingivalis or P. acnes in hTLR2 HEK293 cells, (b) blockade of P. acnes or P. gingivalis signaling by an anti-TLR2 specific antibody, (c) blockade of P. acnes-evoked response by NPT1220-312, and (d) blockade of P. gingivalis-evoked response by NPT1220-312 .
(a)
(b)
(c)
(d)